Javier Francis O, Irawan Cosphiadi, Mansor Marzida Binti, Sriraj Wimonrat, Tan Kian Hian, Thinh Dang Huy Quoc
, St Luke's Medical Center, Metro Manila, Philippines; , University of Indonesia, Jakarta, Indonesia; , University of Malaya, Kuala Lumpur, Malaysia; , Khon Kaen University, Khon Kaen, Thailand; , Singapore General Hospital, Singapore; and , Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam.
J Glob Oncol. 2016 Apr 13;2(4):235-243. doi: 10.1200/JGO.2015.001859. eCollection 2016 Aug.
This expert opinion report examines the current realities of the cancer pain management landscape and the various factors that hinder optimal pain control in six countries in Southeast Asia, describes ongoing efforts to advance patient care, and discusses approaches for improving cancer pain management. Information was gathered from leading experts in the field of cancer pain management in each country through an initial meeting and subsequent e-mail discussions. Overall, there are vast disparities in cancer pain management practices and access to opioids in the Southeast Asian countries. The experts considered cancer pain as being generally undermanaged. Access to opioids is inadequate in most countries, and opioid use for analgesia remains inadequate in the region. Several system-, physician-, and patient-related barriers to adequate pain relief were identified, including widespread over-regulation of opioid use, shortage of trained health care workers, inadequacies in pain assessment and knowledge about managing pain, and widespread resistance among patients and physicians toward opioid treatment. According to the experts, many of the ongoing initiatives in the Southeast Asian countries are related to educating patients and physicians on cancer pain management and opioid use. Efforts to improve opioid availability and reduce regulatory barriers in the region are limited, and much work is still needed to improve the status of cancer pain management in the region. Enacting necessary change will require recognition of the unique needs and resources of each country and collaboration across interdisciplinary professional teams to improve cancer pain care in this region.
本专家意见报告审视了东南亚六个国家癌症疼痛管理的现状以及阻碍实现最佳疼痛控制的各种因素,描述了为推进患者护理所做的持续努力,并讨论了改善癌症疼痛管理的方法。通过首次会议及随后的电子邮件讨论,从每个国家癌症疼痛管理领域的顶尖专家处收集了信息。总体而言,东南亚国家在癌症疼痛管理实践和阿片类药物获取方面存在巨大差异。专家们认为癌症疼痛总体上未得到充分管理。在大多数国家,阿片类药物的获取不足,该地区用于镇痛的阿片类药物使用量仍然不足。确定了几个与系统、医生和患者相关的充分缓解疼痛的障碍,包括阿片类药物使用的广泛过度监管、训练有素的医护人员短缺、疼痛评估不足以及疼痛管理知识欠缺,以及患者和医生对阿片类药物治疗的普遍抵触。专家们表示,东南亚国家目前的许多举措都与对患者和医生进行癌症疼痛管理及阿片类药物使用教育有关。该地区在提高阿片类药物可及性和减少监管障碍方面的努力有限,仍需要开展大量工作来改善该地区癌症疼痛管理的状况。实施必要的变革将需要认识到每个国家的独特需求和资源,并跨跨学科专业团队开展合作,以改善该地区的癌症疼痛护理。